InvestorsHub Logo
Followers 249
Posts 28299
Boards Moderated 2
Alias Born 08/21/2003

Re: matt24d post# 20315

Friday, 01/24/2020 4:34:43 PM

Friday, January 24, 2020 4:34:43 PM

Post# of 27761
Do some dd on HJLI, bro of mine thinks this is a major trade in the future...he follows heart related stuff due to his own heart issues...says it will be huge once it gets done...He's also an old timer like us & is very good at longer picks...may want to dig on it...

Hancock Jaffe Laboratories, Inc. is a development stage medical device company. The Company is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The Company is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

https://www.hancockjaffe.com/coreograft-coronary-artery-bypass-graft/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.